✦ LIBER ✦

P402 Predictors of relapse in patients with ulcerative colitis in remission after one-year of infliximab therapy

✍ Scribed by Molnár, T.; Lakatos, P.L.; Farkas, K.; Bálint, A.; Nagy, F.; Szepes, Z.; Miheller, P.; Palatka, K.; Wittmann, T.

Book ID: 122343847
Publisher: Oxford University Press
Year: 2013
Tongue: English
Weight: 50 KB
Volume: 7
Category: Article
ISSN: 1873-9946
DOI: 10.1016/S1873-9946(13)60423-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictors of Response to Infliximab in

Predictors of Response to Infliximab in Patients With Ulcerative Colitis in Remission After at Least 6 Months of Combination Therapy (Infliximab Plus Azathioprine)

✍ Roblin, Xavier ;Michiels, Christophe ;Presles, Emilie ;Del Tedesco, Emilie ;Hebu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 69 KB

P503 Effectiveness of infliximab as remi

P503 Effectiveness of infliximab as remission-induction therapy in patients with active ulcerative colitis

✍ Yokoyama, K.; Kawagishi, K.; Ooka, S.; Mukae, M.; Sada, M.; Kobayashi, K.; Koizu 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 52 KB

Predictors of relapse in patients with C

Predictors of relapse in patients with Crohn's disease in remission after 1 year of biological therapy

✍ Molnár, T.; Lakatos, P. L.; Farkas, K.; Nagy, F.; Szepes, Z.; Miheller, P.; Horv 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB

TNF-alpha gene expression in colorectal

TNF-alpha gene expression in colorectal mucosa as a predictor of remission after induction therapy with infliximab in ulcerative colitis

✍ Trine Olsen; Rasmus Goll; Guanglin Cui; Ingrid Christiansen; Jon Florholmen 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 203 KB

Predictors of early response to inflixim

Predictors of early response to infliximab in patients with ulcerative colitis

✍ Marc Ferrante; Séverine Vermeire; Konstantinos H. Katsanos; Maja Noman; Gert Van 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 1 views

## Background: Our objective is to report the outcome of infliximab (ifx) in ulcerative colitis (uc) patients from a single center and to identify predictors of early clinical response. ## Methods: The first 100 uc patients (45 female; median age, 37.9 years) who received ifx at a single center w

P404 Predictors of long-term relapse-fre

P404 Predictors of long-term relapse-free and colectomy-free survival in patients with ulcerative colitis treated with infliximab

✍ Ferrante, M.; Arias, M.T.; Vermeire, S.; Noman, M.; Van Assche, G.; Wolthuis, A. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 105 KB